Immunohistochemical expression of ARID1A in penile squamous cell carcinomas

A tissue microarray study of 112 cases

Sheila F. Faraj, Alcides Chaux, Nilda Gonzalez-Roibon, Enrico Munari, Antonio L. Cubilla, Ie Ming Shih, George J. Netto

Research output: Contribution to journalArticle

Abstract

ARID1A, a member of the chromatin remodeling genes family, has been suggested as a novel tumor suppressor gene in gynecologic malignancies. However, its role in penile cancer has yet to be determined. This study assesses the immunohistochemical expression of ARID1A in penile squamous cell carcinoma (SCC) and its association with pathologic features, human papillomavirus (HPV) status, and previously reported mammalian target of rapamycin pathway markers in the same cohort. Four tissue microarrays were constructed from 112 cases of formalin-fixed, paraffin-embedded penile SCC from Paraguay. Each tumor was sampled 3 to 12 times. ARID1A expression was evaluated by immunohistochemistry using a polyclonal rabbit anti-ARID1A (BAF250A) antibody. An H score was calculated in each spot as the sum of expression intensity (0-3+) by extent (0%-100%). Median H score per case was used for statistical analysis. ARID1A expression was observed in all cases, ranging from 3% to 100% of tumor cells (median, 95%). In 96 cases (86%), ARID1A expression was observed in 90% or more tumor cells. HPV DNA was detected in 20 (38%) of 52 analyzed samples. There was a significant trend of association between ARID1A and histologic grade. ARID1A expression was not associated with histologic subtype (P =.61) or HPV status (P =.18). ARID1A expression decreased with decreasing levels of PTEN expression (P =.01). ARID1A was expressed in penile SCC, in most cases at high levels. A significant trend of association was found between histologic grade and ARID1A expression, with lower ARID1A expression, lower histologic grades, and decreased PTEN expression.

Original languageEnglish (US)
Pages (from-to)761-766
Number of pages6
JournalHuman Pathology
Volume46
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Squamous Cell Carcinoma
Neoplasms
Paraguay
Penile Neoplasms
Chromatin Assembly and Disassembly
Sirolimus
Tumor Suppressor Genes
Paraffin
Formaldehyde
Immunohistochemistry
Rabbits
Antibodies
DNA
Genes

Keywords

  • ARID1A
  • BAF250A
  • mTOR pathway
  • Penile SCC
  • SWI/SNF

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Immunohistochemical expression of ARID1A in penile squamous cell carcinomas : A tissue microarray study of 112 cases. / Faraj, Sheila F.; Chaux, Alcides; Gonzalez-Roibon, Nilda; Munari, Enrico; Cubilla, Antonio L.; Shih, Ie Ming; Netto, George J.

In: Human Pathology, Vol. 46, No. 5, 01.05.2015, p. 761-766.

Research output: Contribution to journalArticle

Faraj, Sheila F. ; Chaux, Alcides ; Gonzalez-Roibon, Nilda ; Munari, Enrico ; Cubilla, Antonio L. ; Shih, Ie Ming ; Netto, George J. / Immunohistochemical expression of ARID1A in penile squamous cell carcinomas : A tissue microarray study of 112 cases. In: Human Pathology. 2015 ; Vol. 46, No. 5. pp. 761-766.
@article{b616840f46d846db8304878d189d39d1,
title = "Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: A tissue microarray study of 112 cases",
abstract = "ARID1A, a member of the chromatin remodeling genes family, has been suggested as a novel tumor suppressor gene in gynecologic malignancies. However, its role in penile cancer has yet to be determined. This study assesses the immunohistochemical expression of ARID1A in penile squamous cell carcinoma (SCC) and its association with pathologic features, human papillomavirus (HPV) status, and previously reported mammalian target of rapamycin pathway markers in the same cohort. Four tissue microarrays were constructed from 112 cases of formalin-fixed, paraffin-embedded penile SCC from Paraguay. Each tumor was sampled 3 to 12 times. ARID1A expression was evaluated by immunohistochemistry using a polyclonal rabbit anti-ARID1A (BAF250A) antibody. An H score was calculated in each spot as the sum of expression intensity (0-3+) by extent (0{\%}-100{\%}). Median H score per case was used for statistical analysis. ARID1A expression was observed in all cases, ranging from 3{\%} to 100{\%} of tumor cells (median, 95{\%}). In 96 cases (86{\%}), ARID1A expression was observed in 90{\%} or more tumor cells. HPV DNA was detected in 20 (38{\%}) of 52 analyzed samples. There was a significant trend of association between ARID1A and histologic grade. ARID1A expression was not associated with histologic subtype (P =.61) or HPV status (P =.18). ARID1A expression decreased with decreasing levels of PTEN expression (P =.01). ARID1A was expressed in penile SCC, in most cases at high levels. A significant trend of association was found between histologic grade and ARID1A expression, with lower ARID1A expression, lower histologic grades, and decreased PTEN expression.",
keywords = "ARID1A, BAF250A, mTOR pathway, Penile SCC, SWI/SNF",
author = "Faraj, {Sheila F.} and Alcides Chaux and Nilda Gonzalez-Roibon and Enrico Munari and Cubilla, {Antonio L.} and Shih, {Ie Ming} and Netto, {George J.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.humpath.2015.01.018",
language = "English (US)",
volume = "46",
pages = "761--766",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Immunohistochemical expression of ARID1A in penile squamous cell carcinomas

T2 - A tissue microarray study of 112 cases

AU - Faraj, Sheila F.

AU - Chaux, Alcides

AU - Gonzalez-Roibon, Nilda

AU - Munari, Enrico

AU - Cubilla, Antonio L.

AU - Shih, Ie Ming

AU - Netto, George J.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - ARID1A, a member of the chromatin remodeling genes family, has been suggested as a novel tumor suppressor gene in gynecologic malignancies. However, its role in penile cancer has yet to be determined. This study assesses the immunohistochemical expression of ARID1A in penile squamous cell carcinoma (SCC) and its association with pathologic features, human papillomavirus (HPV) status, and previously reported mammalian target of rapamycin pathway markers in the same cohort. Four tissue microarrays were constructed from 112 cases of formalin-fixed, paraffin-embedded penile SCC from Paraguay. Each tumor was sampled 3 to 12 times. ARID1A expression was evaluated by immunohistochemistry using a polyclonal rabbit anti-ARID1A (BAF250A) antibody. An H score was calculated in each spot as the sum of expression intensity (0-3+) by extent (0%-100%). Median H score per case was used for statistical analysis. ARID1A expression was observed in all cases, ranging from 3% to 100% of tumor cells (median, 95%). In 96 cases (86%), ARID1A expression was observed in 90% or more tumor cells. HPV DNA was detected in 20 (38%) of 52 analyzed samples. There was a significant trend of association between ARID1A and histologic grade. ARID1A expression was not associated with histologic subtype (P =.61) or HPV status (P =.18). ARID1A expression decreased with decreasing levels of PTEN expression (P =.01). ARID1A was expressed in penile SCC, in most cases at high levels. A significant trend of association was found between histologic grade and ARID1A expression, with lower ARID1A expression, lower histologic grades, and decreased PTEN expression.

AB - ARID1A, a member of the chromatin remodeling genes family, has been suggested as a novel tumor suppressor gene in gynecologic malignancies. However, its role in penile cancer has yet to be determined. This study assesses the immunohistochemical expression of ARID1A in penile squamous cell carcinoma (SCC) and its association with pathologic features, human papillomavirus (HPV) status, and previously reported mammalian target of rapamycin pathway markers in the same cohort. Four tissue microarrays were constructed from 112 cases of formalin-fixed, paraffin-embedded penile SCC from Paraguay. Each tumor was sampled 3 to 12 times. ARID1A expression was evaluated by immunohistochemistry using a polyclonal rabbit anti-ARID1A (BAF250A) antibody. An H score was calculated in each spot as the sum of expression intensity (0-3+) by extent (0%-100%). Median H score per case was used for statistical analysis. ARID1A expression was observed in all cases, ranging from 3% to 100% of tumor cells (median, 95%). In 96 cases (86%), ARID1A expression was observed in 90% or more tumor cells. HPV DNA was detected in 20 (38%) of 52 analyzed samples. There was a significant trend of association between ARID1A and histologic grade. ARID1A expression was not associated with histologic subtype (P =.61) or HPV status (P =.18). ARID1A expression decreased with decreasing levels of PTEN expression (P =.01). ARID1A was expressed in penile SCC, in most cases at high levels. A significant trend of association was found between histologic grade and ARID1A expression, with lower ARID1A expression, lower histologic grades, and decreased PTEN expression.

KW - ARID1A

KW - BAF250A

KW - mTOR pathway

KW - Penile SCC

KW - SWI/SNF

UR - http://www.scopus.com/inward/record.url?scp=84930977766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930977766&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2015.01.018

DO - 10.1016/j.humpath.2015.01.018

M3 - Article

VL - 46

SP - 761

EP - 766

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 5

ER -